Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient

Queenan, 2007, Carbapenemases: the versatile beta-lactamases, Clin Microbiol Rev, 20, 440, 10.1128/CMR.00001-07 Walsh, 2005, Metallo-beta-lactamases: the quiet before the storm?, Clin Microbiol Rev, 18, 306, 10.1128/CMR.18.2.306-325.2005 Deshpande, 2006, Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000–2004), Microb Drug Resist, 12, 223, 10.1089/mdr.2006.12.223 Pournaras, 2005, VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid, Antimicrob Agents Chemother, 49, 5153, 10.1128/AAC.49.12.5153-5156.2005 Giakkoupi, 2003, VIM-1 Metallo-betalactamase-producing Klebsiella pneumoniae strains in Greek hospitals, J Clin Microbiol, 41, 3893, 10.1128/JCM.41.8.3893-3896.2003 Aschbacher, 2008, Linkage of acquired quinolone resistance (qnrS1) and metallo-beta-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy, J Antimicrob Chemother, 61, 515, 10.1093/jac/dkm508 Weile, 2009, A VIM-1 metallo-beta-lactamaseproducing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany, Int J Antimicrob Agents, 33, 389, 10.1016/j.ijantimicag.2008.10.015 Tortola, 2005, First detection of a carbapenemhydrolyzing metalloenzyme in two Enterobacteriaceae isolates in Spain, Antimicrob Agents Chemother, 49, 3492, 10.1128/AAC.49.8.3492-3494.2005 Tato, 2007, Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?, Clin Infect Dis, 45, 1171, 10.1086/522288 Psichogiou, 2008, Ongoing epidemic of bla-VIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey, J Antimicrob Chemother, 61, 59, 10.1093/jac/dkm443 Kassis-Chikhani, 2006, First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital, J Antimicrob Chemother, 57, 142, 10.1093/jac/dki389 Ktari, 2006, Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital, Antimicrob Agents Chemother, 50, 4198, 10.1128/AAC.00663-06 Galani, 2008, Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae, J Antimicrob Chemother, 61, 548, 10.1093/jac/dkm535 Picao, 2008, Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates, J Clin Microbiol, 46, 2028, 10.1128/JCM.00818-07 Castanheira, 2008, Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and Metallo-beta-lactamase-producing Enterobacteriaceae. report from the SENTRY antimicrobial surveillance program, Antimicrob Agents Chemother, 52, 570, 10.1128/AAC.01114-07 Conejo, 2008, Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases, Diagn Microbiol Infect Dis, 61, 343, 10.1016/j.diagmicrobio.2008.01.023 2009 Nordmann, 2002, Emerging carbapenemases in Gram-negative aerobes, Clin Microbiol Infect, 8, 321, 10.1046/j.1469-0691.2002.00401.x Coque, 2002, Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000), Antimicrob Agents Chemother, 46, 500, 10.1128/AAC.46.2.500-510.2002 Tenover, 1995, Interpreting chromosomal DNA restriction patterns produced by pulsed- field gel electrophoresis: criteria for bacterial strain typing, J Clin Microbiol, 33, 2233, 10.1128/JCM.33.9.2233-2239.1995 Gulmez, 2008, Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss, Int J Antimicrob Agents, 31, 523, 10.1016/j.ijantimicag.2008.01.017 Hong, 2005, Escherichia coli: developement of carbapenem resistance during therapy, Clin Infect Dis, 40, 84, 10.1086/429822 Giakkoupi, 2005, Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates, J Clin Microbiol, 43, 494, 10.1128/JCM.43.1.494-496.2005 2010 Cobo, 2008, Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta-lactamase-producing Klebsiella pneumoniae epidemic clone, Diagn Microbiol Infect Dis, 60, 319, 10.1016/j.diagmicrobio.2007.09.017 Daly, 2007, Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae, Pharmacotherapy, 27, 1052, 10.1592/phco.27.7.1052 Anthony, 2008, Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline, Clin Infect Dis, 46, 567, 10.1086/526775 Kelesidis, 2008, Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies, J Antimicrob Chemother, 62, 895, 10.1093/jac/dkn311 Keeney, 2007, RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae, Microb Drug Resist, 13, 1, 10.1089/mdr.2006.9990 Rasheed, 1997, Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia, Antimicrob Agents Chemother, 41, 647, 10.1128/AAC.41.3.647 Fishman, 2007, Infection in renal transplant recipients, Semin Nephrol, 27, 445, 10.1016/j.semnephrol.2007.03.006